This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Life Science Institute, Inc., Tohoku University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2022
Title: Innovations of Yoshikatsu Saiki in Aortic Aneurysm Treatment.
Introduction
Yoshikatsu Saiki is a notable inventor based in Sendai, Japan. He has made significant contributions to the field of medical science, particularly in the treatment of vascular disorders. His innovative approach utilizes advanced cell therapy techniques to address critical health issues.
Latest Patents
Saiki holds a patent for a method of treating aortic aneurysm using muse cells. This patent describes a cell product aimed at the prevention and treatment of vascular disorders, specifically aortic aneurysm. The product comprises SSEA-3-positive pluripotent stem cells derived from mesenchymal tissue in a living body or cultured mesenchymal cells, known as Muse cells. This innovative method represents a significant advancement in medical treatment options.
Career Highlights
Throughout his career, Yoshikatsu Saiki has worked with prominent organizations such as Life Science Institute, Inc. and Tohoku University. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Katsuhiro Hosoyama and Mari Dezawa. Their collaborative efforts have furthered the understanding and application of muse cell technology in medical treatments.
Conclusion
Yoshikatsu Saiki's contributions to the field of medical science, particularly through his patent on treating aortic aneurysm, highlight the importance of innovation in healthcare. His work continues to inspire advancements in the treatment of vascular disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile